Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:49 AM UTC
| NCT Number | NCT05548296 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | PHASE2 |
| Target Enrollment | 350 participants |
| Active Locations | 69 sites in the US |
| Sponsor | Acrivon Therapeutics |
| Last Updated on CT.gov | August 21, 2026 (Aug 21, 2026) |
As of October 16, 2026: Clinical trial NCT05548296 is currently recruiting participants. This phase2 study for endometrial cancer is actively seeking new participants at 69 locations across the United States. The study is sponsored by Acrivon Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05548296 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 69 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05548296 was last updated Aug 21, 2026 (August 21, 2026). HelloStudys verifies this status automatically.